Researchers pitted ketamine therapy against electroconvulsive therapy (ECT) — the so-called “gold standard” intervention for severe depression. The study found that ketamine held its own. Six months after the treatments, about half (55%) of ketamine participants experienced at least a 50% improvement in depression symptoms and quality of life measures. That number was 41% for […]
Category: Psychedelics
Ketamine therapy has a long way to go before it becomes a major part of the behavioral health industry. The high-profile stumbles at Field Trip Health & Wellness and Ketamine Wellness Center highlight the fraught environment the half-a-century-old drug faces in treating mental health at scale. It also illustrates the risk of moving too early […]
Psychedelic-assisted treatment provider Field Trip Health & Wellness Ltd. is on the market. This comes after the publicly traded company announced that it was not solvent and searching for a deal to stay afloat while it reorganizes its financial obligations in court. The news marks a huge stumble in a nearly $100 million endeavor to […]
A group of federal lawmakers seeks to remove regulatory barriers that inhibit psychedelics in research and compassionate use cases. Senators Cory Booker (D-N.J.) and Rand Paul (R-KY) introduced an updated version of the Breakthrough Therapies Act to the Senate. If passed, the bill would make it easier to use Schedule 1 drugs with a breakthrough […]
After years of regulatory hurdles and societal stigma, psychedelic-assisted treatment for behavioral health conditions is coming into the spotlight. The growing popularity of psychedelics is due, in part, to promising research results and multiple states relaxing regulations. Now, 2023 could be a banner year for the treatment. Psychedelic legalization is going into effect in the […]
Ketamine therapy startup Nue Life will offer its services to health systems, medical networks and prescribers in all 50 states through its new partnership program. Dubbed Nue Network, the program allows partners to provide patients with at-home ketamine treatment and integrated therapy programs. In addition to the medication, the program also gives patients access to […]
Yet another company that uses psychedelics to treat mental illness is moving into the U.S. market. In June, Vancouver, Canada-based Numinus Wellness (TSX: NUMI) expanded its geographic footprint into the U.S. with its acquisition of Novamind, a mental health company specializing in psychedelic medicine. Novamind is headquartered in Toronto, but its clinics are located in […]
Therapeutic ketamine providers are seeing growth and positive patient outcomes, but companies caution that the business requires guardrails as it expands. The drug ketamine was originally invented in the 1960’s as a surgical anesthetic for humans and animals. But ketamine’s dissociative and hallucinogenic properties meant people have also used it recreationally, and more recently, for […]
Public benefit corporation Osmind Inc. announced Tuesday it completed a $40 million Series B funding round. The San Francisco-based startup will use the funding to further develop its electronic health record (EHR) technology for mental health research and treatment, advance research with new partners, and double the size of its workforce, according to a news […]
Sign up
Receive industry updates and breaking news from Behavioral Health Business